Abstract
Background High resolution 3D late gadolinium enhancement (LGE) imaging prior to RF ablation of atrial fibrillation (AF) is performed with single R-wave gating to reduce lengthy acquisition times [1]. However, this increases the sequence sensitivity to RR interval variations and missed cardiac triggers which cause variable magnetization recovery between sequence repeats, leading to ghosting of blood pool and unsuppressed fat, together with poor myocardial nulling. 3D LGE image quality in AF is consequently often poor. We have developed a dynamic inversion recovery (dynamic-TI) 3D LGE sequence which minimises variations in the longitudinal magnetisation (Mz) of myocardium throughout the acquisition [2] and have performed a study to assess its efficacy in 17 patients in persistent AF.
Highlights
High resolution 3D late gadolinium enhancement (LGE) imaging prior to RF ablation of atrial fibrillation (AF) is performed with single R-wave gating to reduce lengthy acquisition times [1]
The dynamic-TI algorithm adjusts the inversion time automatically from beat-to-beat based on the time since the last sequence repeat [2]
Navigator-gated 3D LGE imaging (32-36 slices, 1.5 × 1.5 × 4 mm, reconstructed to 64-72 slices, 0.7 × 0.7 × .2 mm) with single R-wave gating was performed on a Siemens Avanto 1.5T scanner 15 minutes after gadolinium administration in 17 patients with persistent AF
Summary
High resolution 3D late gadolinium enhancement (LGE) imaging prior to RF ablation of atrial fibrillation (AF) is performed with single R-wave gating to reduce lengthy acquisition times [1]. This increases the sequence sensitivity to RR interval variations and missed cardiac triggers which cause variable magnetization recovery between sequence repeats, leading to ghosting of blood pool and unsuppressed fat, together with poor myocardial nulling. We have developed a dynamic inversion recovery (dynamic-TI) 3D LGE sequence which minimises variations in the longitudinal magnetisation (Mz) of myocardium throughout the acquisition [2] and have performed a study to assess its efficacy in 17 patients in persistent AF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.